Results 21 to 30 of about 1,246,092 (314)

The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe Part 1: patient characteristics and diagnosis [PDF]

open access: yes, 2003
The European Society of Cardiology (ESC) has published guidelines for the investigation of patients with suspected heart failure and, if the diagnosis is proven, their subsequent management.
van Gilst, WH   +47 more
core   +1 more source

Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction [PDF]

open access: yes, 2011
<p><b>Background:</b> The purpose of this study was to examine the prevalence of abnormalities in cardiac structure and function present in patients with heart failure and a preserved ejection fraction (HFPEF) and to determine whether ...
Michel Komajda   +18 more
core   +1 more source

Prevention of heart failure [PDF]

open access: yesCurrent Cardiology Reports, 2002
In light of the increasing prevalence, morbidity, and mortality of heart failure, preventative strategies are urgently needed. Risk factors include coronary artery disease, renal insufficiency, diabetes, and smoking. Essential strategies for prevention of heart failure are modification of risk factors for its development, and detection and treatment of
Tamara B, Horwich, Gregg C, Fonarow
openaire   +3 more sources

Plasma urocortin 1 in human heart failure. [PDF]

open access: yes, 2009
The urocortins are emerging as potentially important contributors to neurohumoral regulation of the circulation with recent reports attributing a powerful array of hemodynamic, renal, and neurohumoral effects to the urocortins in cardiac failure.
Gamble, Gregory   +5 more
core   +1 more source

Modifiable lifestyle factors and heart failure: A Mendelian randomization study [PDF]

open access: yes, 2020
Background: Lifestyle factors may be important targets in the prevention of heart failure. The current knowledge on the relationship between lifestyle factors and heart failure originates mostly from observational studies. The objective of this study was
Handoko, M. Louis   +9 more
core   +1 more source

Ivabradine in Heart Failure [PDF]

open access: yes, 2017
Background: The sinus node inhibitor ivabradine was approved for patients with heart failure (HF) after the ivabradine and outcomes in chronic HF (SHIFT [Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial ...
Das, D.   +26 more
core   +1 more source

Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation – Results from the German EuroAspire IV cohort

open access: yesBMC Cardiovascular Disorders, 2017
Background Adherence to pharmacotherapeutic treatment guidelines in patients with heart failure (HF) is of major prognostic importance, but thorough implementation of guidelines in routine care remains insufficient.
Caroline Morbach   +11 more
doaj   +1 more source

T2 mapping and T2*imaging in heart failure [PDF]

open access: yes, 2017
Cardiovascular magnetic resonance (CMR) is a versatile imaging modality that enables aetiological assessment and provides additional information to that of standard echocardiography in a significant proportion of patients with heart failure.
R.H. Mohiaddin   +5 more
core   +1 more source

Hyperkalemia in heart failure

open access: yesCurrent Opinion in Cardiology, 2020
Purpose of review Hyperkalemia is increasingly prevalent in the heart failure population as more people live with heart failure and comorbid conditions such as diabetes and chronic kidney disease. Furthermore, renin–angiotensin–aldosterone (RAAS) inhibitors are a key component of clinical therapy in these populations. Until now,
Umar Ismail   +2 more
openaire   +5 more sources

Developing new treatments for heart failure: focus on the heart [PDF]

open access: yes, 2016
Compared with heart failure (HF) care 20 to 30 years ago, there has been tremendous advancement in therapy for ambulatory HF with reduced ejection fraction with the use of agents that block maladaptive neurohormonal pathways.
Gheorghiade, M   +22 more
core   +1 more source

Home - About - Disclaimer - Privacy